BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28547577)

  • 21. New pharmacotherapy for Parkinson's disease.
    Gottwald MD; Bainbridge JL; Dowling GA; Aminoff MJ; Alldredge BK
    Ann Pharmacother; 1997 Oct; 31(10):1205-17. PubMed ID: 9337447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A restless abdomen and propriospinal myoclonus like at sleep onset: an unusual overlap syndrome.
    Baiardi S; La Morgia C; Mondini S; Cirignotta F
    BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25820108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute overdose with controlled-release levodopa-carbidopa.
    Delmas G; Rothmann C; Flesch F
    Clin Toxicol (Phila); 2008 Mar; 46(3):274-7. PubMed ID: 18344112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pramipexole extended-release: a review of its use in patients with Parkinson's disease.
    Frampton JE
    Drugs; 2014 Dec; 74(18):2175-90. PubMed ID: 25385556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
    Linazasoro G;
    J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
    Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
    Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bradyarrhythmia due to mirtazapine overdose: A case of serious adverse event in a suicidal patient.
    Kaya FB; Kuas C; Ozakin E; Karakilic ME; Kaya S
    Indian J Pharmacol; 2020; 52(6):520-523. PubMed ID: 33666194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
    Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.
    Lee CS; Lee SD; Kang SH; Park HY; Yoon IY
    Eur J Neurol; 2014 Feb; 21(2):260-6. PubMed ID: 24267148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
    Siuciak JA; Fujiwara RA
    Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.
    Cheah BC; Kiernan MC
    IDrugs; 2010 Dec; 13(12):911-20. PubMed ID: 21154151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
    BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregabalin induced visual hallucinations - a rare adverse reaction.
    Mousailidis G; Papanna B; Salmon A; Sein A; Al-Hillawi Q
    BMC Pharmacol Toxicol; 2020 Feb; 21(1):16. PubMed ID: 32111255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxylamine succinate overdose: Slurred speech and visual hallucination.
    Derinöz-Güleryüz O
    Turk J Pediatr; 2018; 60(4):439-442. PubMed ID: 30859772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ECG Of the Month: Suicide.
    Glancy DL
    J La State Med Soc; 2016; 168(2):66-7. PubMed ID: 27383860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pramipexole in psychiatry: a systematic review of the literature.
    Aiken CB
    J Clin Psychiatry; 2007 Aug; 68(8):1230-6. PubMed ID: 17854248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
    Rocchi C; Albanese M; Placidi F; Romigi A; Lauretti B; Marfia GA; Liguori C; Marciani MG; Mercuri NB; Izzi F
    Sleep Med; 2015 Sep; 16(9):1071-6. PubMed ID: 26298781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overdose of 2.3 grams of intravenous methamphetamine: case, analysis and patient perspective.
    Buffum JC; Shulgin AT
    J Psychoactive Drugs; 2001; 33(4):409-12. PubMed ID: 11824700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.
    Ma JF; Wan Q; Hu XY; Sun SG; Wang WZ; Zhao ZX; Wang YJ; Liu CF; Li JM; Jiang YP; Chen SD
    Sleep Med; 2012 Jan; 13(1):58-63. PubMed ID: 22137119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.